GlassScriptPhysician profile
Tiffany M Walker
NPI 1548453467
$5,517.96
in general payments reported to CMS, 2019-2025
21 companies · $632 in 2025
The $632 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $365 · 2022: $2,074 · 2023: $938 · 2024: $1,510 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,398 · Travel and Lodging: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,397.58 |
| Travel and Lodging | $681.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,413.23 | 2022-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Spinal Simplicity, LLC | $1,002.33 | 2022 | |
| Boston Scientific Corporation | $857.40 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $786.43 | 2021-2024 | Proclaim |
| Collegium Pharmaceutical, INC. | $352.31 | 2021-2025 | Xtampza, Belbuca |
| Nalu Medical, INC. | $295.27 | 2023-2024 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $205.06 | 2022-2025 | Relistor |
| Avanos Medical | $143.49 | 2021-2022 | |
| Averitas Pharma INC. | $104.44 | 2023-2024 | Qutenza |
| Arbor Pharmaceuticals, INC. | $45.93 | 2021-2022 | |
| Impactortho, INC. | $45.32 | 2022 | |
| Grt US Holding, INC. | $44.34 | 2021-2022 | |
| Spr Therapeutics, INC | $39.84 | 2024-2025 | Sprint Pns System |
| Valinor Pharma, LLC | $36.45 | 2024 | Movantik |
| Abbvie INC. | $28.25 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $26.40 | 2021 | |
| Vertos Medical, INC. | $24.17 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.48 | 2025 | |
| Protega Pharmaceutials INC | $18.22 | 2025 | Roxybond |
| Tonix Medicines, INC. | $17.53 | 2025 | Tonmya |
| Orthogenrx INC. | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.